Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder

American Journal of Psychiatry

Volumn 160, Issue 5, 2003, Pages 873-882

  Deicken, Raymond F ^a   Pegues, Mary P ^b   Anzalone, Susan ^b   Feiwell, Robert ^b   Soher, Brian ^b  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATININE; LITHIUM; N ACETYLASPARTIC ACID; VALPROATE SEMISODIUM; ASPARTIC ACID; CREATINE; DRUG DERIVATIVE; N-ACETYLASPARTATE;

ARTICLE; BIPOLAR I DISORDER; CORRELATION ANALYSIS; DISEASE DURATION; HIPPOCAMPUS; HUMAN; NEUTROPHIL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PRIORITY JOURNAL; ADULT; AMBULATORY CARE; BIPOLAR DISORDER; CHEMISTRY; COMPARATIVE STUDY; FAMILY; GENETICS; HEMISPHERIC DOMINANCE; MALE; METABOLISM; MIDDLE AGED; NERVE CELL; NERVE FIBER; NUCLEAR MAGNETIC RESONANCE IMAGING;

ADULT; AMBULATORY CARE; ASPARTIC ACID; AXONS; BIPOLAR DISORDER; CHOLINE; CREATINE; FAMILY; FUNCTIONAL LATERALITY; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEURONS;

EID: 0038521214     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.160.5.873     Document Type: Article

References (86)

1. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS: A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 1998; 44:88-97
2. Pearlson GD, Barta PE, Powers RE, Menon RR, Richards SS, Aylward EH, Federman EB, Chase GA, Petty RG, Tien AY: Ziskind-Somerfeld Research Award 1996: Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biol Psychiatry 1997; 41:1-14
3. Sax KW, Strakowski SM, Zimmerman ME, DelBello MP, Keck PE Jr, Hawkins JM: Frontosubcortical neuroanatomy and the Continuous Performance Test in mania. Am J Psychiatry 1999; 156:139-141
4. Hauser P, Matochik J, Altshuler LL, Denicoff KD, Conrad A, Li X, Post RM: MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders. J Affect Disord 2000; 60:25-32
5. Altshuler LL, Bartzokis G, Grieder T, Curran J, Mintz J: Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity (letter). Arch Gen Psychiatry 1998; 55:663-664
6. Altshuler LL, Bartzokis G, Grieder T, Curran J, Jimenez T, Leight K, Wilkins J, Gerner R, Mintz J: An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia. Biol Psychiatry 2000; 48:147-162
7. Strakowski SM, DelBello MP, Sax KW, Zimmerman ME, Shear PK, Hawkins JM, Larson ER: Brain magnetic resonance imaging of structural abnormalities in bipolar disorder. Arch Gen Psychiatry 1999; 56:254-260
8. Swayze VW II, Andreasen NC, Alliger RJ, Yuh WT, Ehrhardt JC: Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study. Biol Psychiatry 1992; 31:221-240
9. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW: Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci USA 1996; 93:3908-3913
10. Shah PJ, Ebmeier KP, Glabus MF, Goodwin GM: Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression: controlled magnetic resonance imaging study. Br J Psychiatry 1998; 172:527-532
11. Bremner JD, Narayan M, Anderson ER, Staib LH, Miller HL, Charney DS: Hippocampal volume reduction in major depression. Am J Psychiatry 2000; 157:115-117
12. Truckenmiller ME, Namboodiri MA, Brownstein MJ, Neale JH: N-Acetylation of L-aspartate in the nervous system: differential distribution of a specific enzyme. J Neurochem 1985; 45:1658-1662
13. Simmons ML, Frondoza CG, Coyle JT: Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 1991; 45:37-45
14. 1H nuclear magnetic resonance spectroscopic imaging of neuronal loss in rat brain. Neuroscience 1995; 69:1095-1101
15. 1H magnetic resonance spectroscopic imaging analysis of quinolinic acid-induced damage to the rat striatum. Magn Reson Med 1997; 37:24-33
16. 1H-MRS and unbiased stereology: can non-invasive measures of N-acetyl-aspartate following global ischemia be used as a reliable measure of neuronal damage? Brain Res 2001; 892:166-175
17. De Stefano N, Matthews PM, Arnold DL: Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995; 34:721-727
18. Tsai G, Coyle JT: N-Acetylaspartate in neuropsychiatric disorders. Prog Neurobiol 1995; 46:531-540
19. 1H magnetic resonance spectroscopic imaging. Ann Neurol 1996; 40:236-239
20. Manji HK, Moore GJ, Chen G: Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry 2000; 48:740-754
21. Deicken RF, Pegues M, Amend D: Reduced hippocampal N-acetylaspartate without volume loss in schizophrenia. Schizophr Res 1999; 37:217-223
22. Barker PB, Breiter SN, Soher BJ, Chatham JC, Forder JR, Samphilipo MA, Magee CA, Anderson JH: Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations. Magn Reson Med 1994; 32:157-163
23. Bluml S, Seymour K, Ross B: Developmental changes in choline- and ethanolamine-containing compounds measured with proton-decoupled (31)P MRS in vivo human brain. Magn Reson Med 1999; 42:643-654
24. Ross B, Michaelis T: Clinical applications of magnetic resonance spectroscopy. Magn Reson Quarterly 1994; 10:191-247
25. Tedeschi G, Bertolino A, Righini A, Campbell G, Raman R, Duyn JH, Moonen CT, Alger JR, Di Chiro G: Brain regional distribution pattern of metabolite signal intensities in young adults by proton magnetic resonance spectroscopic imaging. Neurology 1995; 45:1384-1391
26. Stoll AL, Renshaw PF, De Micheli E, Wurtman R, Pillay SS, Cohen BM: Choline ingestion increases the resonance of choline-containing compounds in human brain: an in vivo proton magnetic resonance study. Biol Psychiatry 1995; 37:170-174
27. Cohen BM, Renshaw PF, Stoll AL, Wurtman RJ, Yurgelun-Todd D, Babb SM: Decreased brain choline uptake in older adults: an in vivo proton magnetic resonance spectroscopy study. JAMA 1995; 274:902-907
28. Tan J, Bluml S, Hoang T, Dubowitz D, Mevenkamp G, Ross B: Lack of effect of oral choline supplement on the concentrations of choline metabolites in human brain. Magn Reson Med 1998; 39:1005-1010
29. Dechent P, Pouwels PJ, Frahm J: Neither short-term nor long-term administration of oral choline alters metabolite concentrations in human brain. Biol Psychiatry 1999; 46:406-411
30. Renshaw PF, Yurgelun-Todd DA, Tohen M, Gruber S, Cohen BM: Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis. Am J Psychiatry 1995; 152:444-446
31. Drevets WC, Price JL, Simpson JR Jr, Todd RD, Reich T, Vannier M, Raichle ME: Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997; 386:824-827
32. Ongür D, Drevets WC, Price JL: Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci USA 1998; 95:13290-13295
33. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P), version 2. New York, New York State Psychiatric Institute, Biometrics Research, 1995
34. Annett M: A classification of hand preference by association analysis. Br J Psychol 1970; 61:303-321
35. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133:429-435
36. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
37. Maudsley AA, Matson GB, Hugg JW, Weiner MW: Reduced phase encoding in spectroscopic imaging. Magn Reson Med 1994; 31:645-651
38. Deicken RF, Eliaz Y, Feiwell R, Schuff N: Increased thalamic N-acetylaspartate in male patients with familial bipolar I disorder. Psychiatry Res Neuroimaging2001; 106:35-45
39. Cardenas VA, Ezekiel F, Di Sclafani V, Gomberg B, Fein G: Reliability of tissue volumes and their spatial distribution for segmented magnetic resonance images. Psychiatry Res Neuroimaging 2001; 106:193-205
40. Collins DL, Zijdenbos AP, Kollokian V, Sled JG, Kabani NJ, Holmes CJ, Evans AC: Design and construction of a realistic digital brain phantom. IEEE Trans Med Imaging 1998; 17:463-468
41. Kwan RK, Evans AC, Pike GB: MRI simulation-based evaluation of image-processing and classification methods. IEEE Trans Med Imaging 1999; 18:1085-1097
42. Maudsley AA, Lin E, Weiner MW: Spectroscopic imaging display and analysis. Magn Reson Imaging 1992; 10:471-485
43. Soher BJ, Young K, Govindaraju V, Maudsley AA: Automated spectral analysis, III: application to in vivo proton MR spectroscopy and spectroscopic imaging. Magn Reson Med 1998; 40:822-831
44. Schuff N, Amend D, Ezekiel F, Steinman SK, Tanabe J, Norman D, Jagust W, Kramer JH, Mastrianni JA, Fein G, Weiner MW: Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease: a proton MR spectroscopic imaging and MRI study. Neurology 1997; 49:1513-1521
45. Schuff N, Amend DL, Meyerhoff DJ, Tanabe JL, Norman D, Fein G, Weiner MW: Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain. Radiology 1998; 207:91-102
46. Winsberg ME, Sachs N, Tate DL, Adalsteinsson E, Spielman D, Ketter TA: Decreased dorsolateral prefrontal N-acetyl aspartate in bipolar disorder. Biol Psychiatry 2000; 47:475-481
47. Ohara K, Isoda H, Suzuki Y, Takehara Y, Ochiai M, Takeda H, Igarashi Y: Proton magnetic resonance spectroscopy of the lenticular nuclei in bipolar I affective disorder. Psychiatry Res 1998; 84:55-60
48. Hamakawa H, Kato T, Shioiri T, Inubushi T, Kato N: Quantitative proton magnetic resonance spectroscopy of the bilateral frontal lobes in patients with bipolar disorder. Psychol Med 1999; 29:639-644
49. McEwen BS: Stress and hippocampal plasticity. Annu Rev Neurosci 1999; 22:105-122
50. Gould E, McEwen BS, Tanapat P, Galea LA, Fuchs E: Neurogenesis in the dentate gyrus of the adult tree shrew is regulated by psychosocial stress and NMDA receptor activation. J Neurosci 1997; 17:2492-2498
51. Gould E, Tanapat P, McEwen BS, Flugge G, Fuchs E: Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc Natl Acad Sci USA 1998; 95:3168-3171
52. Sapolsky RM: Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 2000; 57:925-935
53. Sapolsky RM: The possibility of neurotoxicity in the hippocampus in major depression: a primer on neuron death. Biol Psychiatry 2000; 48:755-765
54. Smith MA, Makino S, Kvetnansky R, Post RM: Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 1995; 15:1768-1777
55. McAllister AK, Katz LC, Lo DC: Neurotrophins and synaptic plasticity. Annu Rev Neurosci 1999; 22:295-318
56. Adams JM, Cory S: The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281:1322-1326
57. Bruckheimer EM, Cho SH, Sarkiss M, Herrmann J, McDonnell TJ: The Bcl-2 gene family and apoptosis. Adv Biochem Eng Biotech 1998; 62:75-105
58. Chen DF, Schneider GE, Martinou JC, Tonegawa S: Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 1997; 385:434-439
59. Dowlatshahi D, MacQueen GM, Wang JF, Young LT: Increased temporal cortex CREB concentrations and antidepressant treatment in major depression. Lancet 1998; 352:1754-1755
60. Nibuya M, Morinobu S, Duman RS: Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995; 15:7539-7547
61. Nibuya M, Nestler EJ, Duman RS: Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996; 16:2365-2372
62. Thome J, Sakai N, Shin K, Steffen C, Zhang YJ, Impey S, Storm D, Duman RS: cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci 2000; 20:4030-4036
63. Fatemi SH, Kroll JL, Stary JM: Altered levels of reelin and its isoforms in schizophrenia and mood disorders. Neuroreport 2001; 12:3209-3215
64. Guidotti A, Auta J, Davis JM, DiGiorgi Gerevini V, Dwivedi Y, Grayson DR, Impagnatiello F, Pandey G, Pesold C, Sharma R, Uzunov D, Costa E: Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000; 57:1061-1069; correction, 2002; 59:12
65. Grant SG, Karl KA, Kiebler MA, Kandel ER: Focal adhesion kinase in the brain: novel subcellular localization and specific regulation by Fyn tyrosine kinase in mutant mice. Genes Dev 1995; 9:1909-1921
66. Costa E, Davis J, Resold C, Tueting P, Guidotti A: The heterozygote reeler mouse as a model for the development of a new generation of antipsychotics. Curr Opin Pharmacol 2002; 2:56-62
67. Knable MB, Torrey EF, Webster MJ, Bartko JJ: Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res Bull 2001; 55:651-659
68. Fatemi SH, Earle JA, McMenomy T: Reduction in reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 2000; 5:654-663
69. Bertolino A, Nawroz S, Mattay VS, Barnett AS, Duyn JH, Moonen CTW, Frank JA, Tedeschi G, Weinberger DR: Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1996; 153:1554-1563
70. Bertolino A, Callicott JH, Elman I, Mattay VS, Tedeschi G, Frank JA, Breier A, Weinberger DR: Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 1998; 43:641-648
71. Bertolino A, Kumra S, Callicott JH, Mattay VS, Lestz RM, Jacobsen L, Barnett IS, Duyn JH, Frank JA, Rapoport JL, Weinberger DR: Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging. Am J Psychiatry 1998; 155:1376-1383
72. Deicken RF, Zhou L, Schuff N, Fein G, Weiner MW: Hippocampal neuronal dysfunction in schizophrenia as measured by proton magnetic resonance spectroscopy. Biol Psychiatry 1998; 43:483-488
73. Maier M, Ron MA: Hippocampal age-related changes in schizophrenia: a proton magnetic resonance spectroscopy study. Schizophr Res 1996; 22:5-17
74. Kegeles LS, Shungu DC, Anjilvel S, Chan S, Ellis SP, Xanthopoulos E, Malaspina D, Gorman JM, Mann JJ, Lamelle M, Kaufmann CA: Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies. Psychiatry Res Neuroimaging 2000; 98:163-175
75. Yurgelun-Todd DA, Renshaw PF, Gruber SA, Ed M, Waternaux C, Cohen BM: Proton magnetic resonance spectroscopy of the temporal lobes in schizophrenics and normal controls. Schizophr Res 1996; 19:55-59
76. 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates. Biol Psychiatry 1994; 36:792-800
77. Fukuzako H, Takeuchi K, Hokazono Y, Fukuzako T, Yamada K, Hashiguchi T, Obo Y, Ueyama K, Takigawa M, Fujimoto T: Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report. Psychiatry Res 1995; 61:193-200
78. Altshuler LL, Conrad A, Hauser P, Li XM, Guze BH, Denikoff K, Tourtellotte W, Post R: Reduction of temporal lobe volume in bipolar disorder: a preliminary report of magnetic resonance imaging. Arch Gen Psychiatry 1991; 48:482-483
79. Ende G, Braus DF, Walter S, Weber-Fahr W, Soher B, Maudsley AA, Henn FA: Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophr Res 2000; 41:389-395
80. Bertolino A, Callicott JH, Mattay VS, Weidenhammer KM, Rakow R, Egan MF, Weinberger DR: The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol Psychiatry 2001; 49:39-46
81. Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB, Faulk MW, Koch S, Glitz DA, Jolkovsky L, Manji HK: Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol Psychiatry 2000; 48:1-8
82. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK: Lithium-induced increase in human brain grey matter. Lancet 2000; 356:1241-1242
83. Jacobs BL, Praag H, Gage FH: Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 2000; 5:262-269
84. Malberg JE, Eisch AJ, Nestler EJ, Duman RS: Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 2000; 20:9104-9110
85. Manev H, Uz T, Smalheiser NR, Manev R: Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro. Eur J Pharmacol 2001; 411:67-70
86. Duman RS, Nakagawa S, Malberg J: Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 2001; 25:836-844